NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
NU SKIN ENTERPRISES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$4.97−0.17 (-3.31%)
Close on Oct 19, 2026
- Market cap
- $241.52M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$5.72 (−53.51%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
NU SKIN ENTERPRISES, INC. saw revenue fall 15.4% to $1.38B over the twelve months to Jun 30, 2026. Free cash flow was $10.78M, down 81.6% from a year earlier.
Revenue
$1.38B
-15.4% vs. a year earlier
Operating income
-$10.41M
TTM Q2 2026
Free cash flow
$10.78M
-81.6% vs. a year earlier
EPS, diluted
-$4.47
-322.4% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $241.52M
- P/E ratio
- –
- Price to sales
- 0.18
- Price to book
- 0.45
- Dividend yield
- –
- Free cash flow yield
- 4.46%
Fundamentals
- Revenue
- $1.38B
- Net income
- -$216.39M
- EPS, diluted
- -$4.47
- Free cash flow
- $10.78M
- Book value per share
- $11.17
- Diluted shares
- 49M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$1.38B-15.4% YoY
Gross profit
$951.49M-13.0% YoY
Operating income
-$10.41M
Net income
-$216.39M-314.6% YoY
EPS, diluted
-$4.47-322.4% YoY
Free cash flow
$10.78M-81.6% YoY
Reported periodTrailing twelve months